QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Sara Hallberg, Jonas Banefelt, and Johan Mesterton published in The International Journal of Clinical Practice
The paper “Lipid-lowering treatment patterns in patients with new cardiovascular events – estimates from population-based register data in Sweden”, co-authored by Sara Hallberg, Jonas Banefelt, and Johan Mesterton of Quantify Research, has been published in The International Journal of Clinical Practice. Pubmed link
AutoPilot DX awarded grant from the European Union
AutoPilot DX, a project lead by MeMed diagnostics, has been awarded a grant from the European Union to bring to market and conduct analyses on its tools for distinguishing between bacterial and viral infections. Quantify Research is a partner in the consortium, set to conduct health economic analyses and craft a reimbursement strategy. More information can be found here.
Jonas Banefelt, Sara Hallberg, and Johan Mesterton published in The European Journal of Health Economics
The paper “Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden”, co-authored by Jonas Banefelt, Sara Hallberg, and Johan Mesterton of Quantify Research, has been published in The European Journal of Health Economics. Pubmed link
Quantify Research October 2015 newsletter published
Quantify Research have published a newsletter for October 2015. The newsletter reflects on developments within the fields of market access and health economic outcomes research. The newsletter also contains details on Quantify Research’s presence at the upcomingISPOR European Congress in Milan. We hope to see you there!